Allstate Corporation’s Chemed CHE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-2,810
Closed -$1.49M 619
2021
Q4
$1.49M Sell
2,810
-113
-4% -$54.3K 0.03% 456
2021
Q3
$1.36M Buy
2,923
+8
+0.3% +$3.77K 0.06% 213
2021
Q2
$1.38M Sell
2,915
-684
-19% -$328K 0.05% 225
2021
Q1
$1.66M Buy
3,599
+1,116
+45% +$547K 0.05% 200
2020
Q4
$1.32M Buy
2,483
+711
+40% +$349K 0.04% 223
2020
Q3
$851K Buy
1,772
+39
+2% +$19.1K 0.03% 279
2020
Q2
$782K Buy
+1,733
New +$774K 0.03% 313

Other funds holding CHE

Allstate Corporation's CHE Position: Q1 2022 in Review

Allstate Corporation sold out of Chemed (CHE) in Q1 2022, closing a stake of 2,810 shares — an estimated $1.49M sold.

Allstate Corporation first reported a position in CHE in Q2 2020 and held it in 7 quarters. The position peaked at $1.66M in Q1 2021. 425 funds tracked by Wall St. Rank hold CHE as of Q1 2022.

  • Allstate Corporation reported no remaining Chemed position as of Q1 2022 after selling out during the quarter.
  • Allstate Corporation sold 2,810 Chemed shares in Q1 2022, an estimated $1.49M.
  • Allstate Corporation first reported a position in Chemed in Q2 2020 and held it in 7 quarters.
  • Allstate Corporation's Chemed position peaked at $1.66M in Q1 2021.
  • 425 funds tracked by Wall St. Rank held Chemed as of Q1 2022.

Based on Allstate Corporation's 13F filing for Q1 2022, filed 16 May 2022.